Shimada M - Search Results

1

Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.

Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N. Oishi T, et al. Among authors: shimada m. Obstet Gynecol. 1998 Apr;91(4):568-71. doi: 10.1016/s0029-7844(98)00044-1. Obstet Gynecol. 1998. PMID: 9540942

2

[The clinical evaluation of hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer employing an implanted port system].

Takahashi M, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, Ooki H, Toyoda H, Shimada M, Samori T, Hayashi K. Takahashi M, et al. Among authors: shimada m. Nihon Shokakibyo Gakkai Zasshi. 1996 Jan;93(1):10-8. Nihon Shokakibyo Gakkai Zasshi. 1996. PMID: 8642753 Japanese.

3

Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.

Okada M, Kigawa J, Minagawa Y, Kanamori Y, Shimada M, Takahashi M, Oishi T, Terakawa N. Okada M, et al. Among authors: shimada m. Gynecol Oncol. 1998 Jul;70(1):61-4. doi: 10.1006/gyno.1998.5005. Gynecol Oncol. 1998. PMID: 9698475 Clinical Trial.

4

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.

Kanamori Y, Kigawa J, Minagawa Y, Irie T, Oishi T, Shimada M, Takahashi M, Nakamura T, Sato K, Terakawa N. Kanamori Y, et al. Among authors: shimada m. Eur J Cancer. 1998 Oct;34(11):1802-6. doi: 10.1016/s0959-8049(98)00199-3. Eur J Cancer. 1998. PMID: 9893672

5

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma.

Sato S, Kigawa J, Minagawa Y, Okada M, Shimada M, Takahashi M, Kamazawa S, Terakawa N. Sato S, et al. Among authors: shimada m. Cancer. 1999 Oct 1;86(7):1307-13. Cancer. 1999. PMID: 10506718

6

Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer.

Shimada M, Kigawa J, Minagawa Y, Irie T, Takahashi M, Terakawa N. Shimada M, et al. Am J Clin Oncol. 1999 Oct;22(5):481-4. doi: 10.1097/00000421-199910000-00012. Am J Clin Oncol. 1999. PMID: 10521063

7

Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways.

Minagawa Y, Kigawa J, Itamochi H, Kanamori Y, Shimada M, Takahashi M, Terakawa N. Minagawa Y, et al. Among authors: shimada m. Jpn J Cancer Res. 1999 Dec;90(12):1373-9. doi: 10.1111/j.1349-7006.1999.tb00722.x. Jpn J Cancer Res. 1999. PMID: 10665656 Free PMC article.

8

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Takahashi M, Kigawa J, Oishi T, Itamochi H, Shimada M, Sato S, Kamazawa S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: shimada m. Gynecol Obstet Invest. 2000;49(3):204-8. doi: 10.1159/000010247. Gynecol Obstet Invest. 2000. PMID: 10729763

9

Alteration of a p53 gene status affects outcome of patients with recurrent ovarian cancer.

Irie T, Kigawa J, Minagawa Y, Oishi T, Takahashi M, Shimada M, Kamazawa S, Sato S, Terakawa N. Irie T, et al. Among authors: shimada m. Oncology. 2000 Apr;58(3):237-41. doi: 10.1159/000012106. Oncology. 2000. PMID: 10765126

10

Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells.

Takahashi M, Kigawa J, Minagawa Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: shimada m. Eur J Cancer. 2000 Sep;36(14):1863-8. doi: 10.1016/s0959-8049(00)00183-0. Eur J Cancer. 2000. PMID: 10974635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,273 results

Search Page

Filters